AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
LSE:AZN
Price:
12 172 GBX
-0.6%
Market Closed
Updated:
May 15, 2024
AstraZeneca PLC
Net Issuance of Common Stock
|
AstraZeneca PLC
Net Issuance of Common Stock Peer Comparison
Comparables:
GSK
VRNA
INDV
HIK
DPH
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AstraZeneca PLC
LSE:AZN
|
Net Issuance of Common Stock
$35m
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-24%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Net Issuance of Common Stock
£22m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Net Issuance of Common Stock
$1.9m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Net Issuance of Common Stock
-$55m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Net Issuance of Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Net Issuance of Common Stock
£181.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
71%
|
See Also
What is AstraZeneca PLC's Net Issuance of Common Stock?
Net Issuance of Common Stock
35m
USD
35m
USD
Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Net Issuance of Common Stock amounts to 35m USD.
What is AstraZeneca PLC's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-24%
-24%
Over the last year, the Net Issuance of Common Stock growth was 25%. The average annual Net Issuance of Common Stock growth rates for AstraZeneca PLC have been 6% over the past three years , 2% over the past five years , and -24% over the past ten years .
You don't have any saved screeners yet
